missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human BRUNOL4 (aa 314-369) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (100%), Rat (100%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-139747 (PA5-139747. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Members of the CELF/BRUNOL protein family contain two N-terminal RNA recognition motif (RRM) domains, one C-terminal RRM domain, and a divergent segment of 160-230 aa between the second and third RRM domains. Members of this protein family regulate pre-mRNA alternative splicing and may also be involved in mRNA editing, and translation. Multiple transcript variants encoding different isoforms have been found for this gene.
Specifications
Specifications
| Accession Number | Q9BZC1 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 56853 |
| Name | Human BRUNOL4 (aa 314-369) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | A230070D14Rik; Brul4; Bruno -like 4; brunol4; BRUNOL-4; bruno-like 4, RNA binding protein; bruno-like protein 4; C130060B05Rik; celf4; CELF-4; CUGBP; CUG-BP and ETR-3 like factor 4; CUG-BP- and ETR-3-like factor 4; CUGBP Elav-like family member 4; CUGBP, Elav-like family member 4; LYST-interacting protein LIP9; RNA-binding protein BRUNOL4; RNA-binding protein BRUNOL-4; zgc:92761 |
| Common Name | BRUNOL4 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction